Treating Allergic Itch: Improving the Quality of Life for Dogs and their Owners with Veterinary Dermatologist Dr. Dana Liska

Published: Aug. 28, 2019, 9 a.m.

b'Itching dogs update with Veterinary Dermatologist Dr. Dana Liska! Once again we\'re thrilled to share the podcast with veterinary dermatologist Dr. Liska from Zoetis. This time we review why so many dogs develop allergic dermatitis, the latest news and strategies in diagnosis and treatment, and how allergies may negatively impact a pet\'s (and pet parent\'s) quality of life. This is an excellent episode for all team members to review as we enter another "allergy season!" \\n\\nThis podcast is sponsored by Zoetis, the makers of treatments including APOQUEL and CYTOPOINT.\\n\\nImportant Safety Information\\nDo not use APOQUEL\\xae (oclacitinib tablet) in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or preexisting cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.\\nFor more information, please see the full Prescribing Information at apoquel.com.\\nCYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.\\n\\nZoetis is dedicated to changing the way we approach canine pruritus to protect the bonds that matter most. Visit ScienceofStrongerBonds.com for more.'